Key market opportunities in the inhaler solution market include the rising demand driven by increased respiratory disorders like asthma and COPD, expanding access to medicines in low and middle-income ...
"Soon, I could walk farther without needing my asthma inhaler, and exercise began to feel easier and more enjoyable." ...
Move comes 2 years after controversial exit of brand-name product ...
Frome Medical Practice in Somerset saves £278,968 and cuts CO2 emissions with its 'Order What You Need' prescription waste ...
I suffered for a year with extreme asthma symptoms, not helped by an inhaler like Advair. After a CT scan last month, a pulmonologist prescribed the antibiotic azithromycin. I am supposed to take ...
Medication nonadherence among people with chronic obstructive pulmonary disease (COPD) is a result of affordability and lack of knowledge about medications, among other factors, and leads to increased ...
Medication nonadherence among people with chronic obstructive pulmonary disease (COPD) is a result of affordability and lack of knowledge about medications, among other factors, and leads to increased ...
Inhaled corticosteroid–long-acting beta-agonist (ICS-LABA) inhalers are widely prescribed for asthma and chronic obstructive pulmonary disease. ICS-LABAs are largely interchangeable within the class; ...
Medication nonadherence among people with chronic obstructive pulmonary disease (COPD) is a result of affordability and lack of knowledge about medications, among other factors, and leads to increased ...
Sometimes the story can be told in statistics. India accounts for 13% of the global population, yet it accounts for 42% of global asthma mortality. Around 35 million Indians are thought to be living ...
Medication non-adherence among people with chronic obstructive pulmonary disease (COPD) is a result of lack of affordability and lack of knowledge about medications, among other factors, according ...
Key opportunities in the drug delivery devices market include expanding digital health partnerships for innovative injectable ...